The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a ...

Oak Street Health, a subsidiary of CVS, is paying $60 million to the federal government to resolve allegations that it ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

After the market panicked and sold CVS Health in spring, the current price makes for a good opportunity. Find out why CVS ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

CVS Health Corp. closed $24.85 short of its 52-week high ($83.25), which the company reached on January 8th.